LIXTE BIOTECHNOLOGY HOLDINGS (LIXT)
US5393192027 - Common Stock
0.6625 -0.03 (-4.37%)
After market: 0.7 +0.04 (+5.66%)
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 6.03M | 6.31M | 6.72M | 3.27M | 2.49M | |||
| Interest Expense | 3.99K | -1.06K | -7.95K | 0.00 | 50.00K | |||
| Income Before Taxes | -6.02M | -6.31M | -6.73M | -3.26M | -2.44M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -6.02M | -6.31M | -6.73M | -3.26M | -2.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.36 | -0.40 | -0.50 | -0.29 | -0.22 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD